Loading...
Arjo AB (publ)
ARRJF•PNK
Healthcare
Medical - Distribution
$3.07
$0.00(0.00%)
Arjo AB (publ) (ARRJF) Financial Performance & Income Statement Overview
Review Arjo AB (publ)’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
2.84%
↑ 2.84%
Operating Income Growth
1.02%
↑ 1.02%
Net Income Growth
3.75%
↑ 3.75%
Operating Cash Flow Growth
-26.44%
↓ 26.44%
Operating Margin
7.49%
↑ 7.49%
Gross Margin
42.70%
↑ 42.70%
Net Profit Margin
4.02%
↑ 4.02%
ROE
5.73%
↑ 5.73%
ROIC
7.85%
↑ 7.85%
Arjo AB (publ) (ARRJF) Income Statement & Financial Overview
Review Arjo AB (publ)'s (ARRJF) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $2.86B | $2.99B | $2.73B | $2.81B |
| Cost of Revenue | $1.61B | $1.65B | $1.59B | $1.68B |
| Gross Profit | $1.25B | $1.34B | $1.15B | $1.13B |
| Gross Profit Ratio | $0.44 | $0.45 | $0.42 | $0.40 |
| R&D Expenses | $39.00M | $34.00M | $37.00M | $38.00M |
| SG&A Expenses | $971.00M | $947.00M | $933.00M | $855.00M |
| Operating Expenses | $1.08B | $1.05B | $989.00M | $893.00M |
| Total Costs & Expenses | $2.69B | $2.70B | $2.58B | $2.57B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $59.00M | $65.00M |
| Depreciation & Amortization | $278.00M | $296.00M | $270.00M | $264.00M |
| EBITDA | $486.00M | $671.00M | $437.00M | $497.00M |
| EBITDA Ratio | $0.17 | $0.22 | $0.16 | $0.18 |
| Operating Income | $168.00M | $287.00M | $158.00M | $240.00M |
| Operating Income Ratio | $0.06 | $0.10 | $0.06 | $0.09 |
| Other Income/Expenses (Net) | -$43.00M | -$42.00M | -$58.00M | -$62.00M |
| Income Before Tax | $125.00M | $245.00M | $100.00M | $167.00M |
| Income Before Tax Ratio | $0.04 | $0.08 | $0.04 | $0.06 |
| Income Tax Expense | $34.00M | $72.00M | $27.00M | $44.00M |
| Net Income | $91.00M | $174.00M | $73.00M | $120.00M |
| Net Income Ratio | $0.03 | $0.06 | $0.03 | $0.04 |
| EPS | $0.33 | $0.64 | $0.27 | $0.44 |
| Diluted EPS | $0.33 | $0.64 | $0.27 | $0.44 |
| Weighted Avg Shares Outstanding | $272.37M | $272.37M | $272.37M | $272.37M |
| Weighted Avg Shares Outstanding (Diluted) | $272.37M | $272.37M | $272.37M | $272.37M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan